{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:00:25Z","timestamp":1777435225488,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM23\/00104"],"award-info":[{"award-number":["CM23\/00104"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI23\/00074"],"award-info":[{"award-number":["FI23\/00074"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01212"],"award-info":[{"award-number":["PI22\/01212"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM23\/00095"],"award-info":[{"award-number":["CM23\/00095"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/00851"],"award-info":[{"award-number":["PI23\/00851"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/00920"],"award-info":[{"award-number":["PI24\/00920"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR21\/00026"],"award-info":[{"award-number":["JR21\/00026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Publica Galega de investigaci\u00f3n Biom\u00e9dica (INIBIC) and Xunta de Galicia","award":["IN606A 2024\/022"],"award-info":[{"award-number":["IN606A 2024\/022"]}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00055"],"award-info":[{"award-number":["CB21\/13\/00055"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00055"],"award-info":[{"award-number":["CB21\/13\/00055"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00055"],"award-info":[{"award-number":["CB21\/13\/00055"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607D 2021\/12"],"award-info":[{"award-number":["IN607D 2021\/12"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607A 2024\/09"],"award-info":[{"award-number":["IN607A 2024\/09"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","award":["IN607D 2024\/008"],"award-info":[{"award-number":["IN607D 2024\/008"]}],"id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10096-025-05352-w","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:26:24Z","timestamp":1762820784000},"page":"631-640","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo evolution of resistance to novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations through overproduction of the horizontally acquired extended-spectrum AmpC \u03b2-lactamase FOX-14 and porin disruption in Serratia marcescens"],"prefix":"10.1007","volume":"45","author":[{"given":"Salud","family":"Rodr\u00edguez-Pallares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Tarri\u00f1o-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Aja-Macaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"S\u00e1nchez-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Moscoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"P\u00e9rez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Blanco-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Beceiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n","family":"Bou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Arca-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"5352_CR1","doi-asserted-by":"publisher","first-page":"e0305423","DOI":"10.1128\/mbio.03054-23","volume":"15","author":"S Aracil-Gisbert","year":"2024","unstructured":"Aracil-Gisbert S, Fern\u00e1ndez-De-Bobadilla MD, Guerra-Pinto N, Serrano-Calleja S, P\u00e9rez-Cobas AE, Soriano C, de Pablo R, Lanza VF, P\u00e9rez-Viso B, Reuters S, Hasman H, Cant\u00f3n R, Baquero F, Coque TM (2024) The ICU environment contributes to the endemicity of the Serratia marcescens complex in the hospital setting. mBio 15:e0305423. https:\/\/doi.org\/10.1128\/mbio.03054-23","journal-title":"mBio"},{"key":"5352_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/S41564-021-00870-7","volume":"6","author":"K Sands","year":"2025","unstructured":"Sands K, Carvalho MJ, Portal E, Thomson K, Dyer C, Akpulu C, Andrews R, Ferreira A, Gillespie D, Hender T, Hood K, Mathias J, Milton R, Nieto M, Taiyari K, Chan GJ, Bekele D, Solomon S, Basu S, Chattopadhyay P, Mukherjee S, Iregbu K, Modibbo F, Uwaezuoke S, Zahra R, Shirazi H, Muhammad A, Mazarati JB, Rucogoza A, Gaju L, Mehtar S, Bulabula ANH, Whitelaw A, BARNARDS Group, Walsh TR (2025) Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries. Nat Microbiol 6:512\u2013523. https:\/\/doi.org\/10.1038\/S41564-021-00870-7","journal-title":"Nat Microbiol"},{"key":"5352_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/jac\/dky084","volume":"73","author":"R Kohlmann","year":"2018","unstructured":"Kohlmann R, B\u00e4hr T, Gatermann SG (2018) Species-specific mutation rates for AmpC derepression in enterobacterales with chromosomally encoded inducible AmpC \u03b2-lactamase. J Antimicrob Chemother 73:1530\u20131536. https:\/\/doi.org\/10.1093\/jac\/dky084","journal-title":"J Antimicrob Chemother"},{"key":"5352_CR4","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/ciz173","volume":"69","author":"PD Tamma","year":"2019","unstructured":"Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ (2019) A primer on AmpC \u03b2-lactamases: necessary knowledge for an increasingly multidrug-resistant world. Clin Infect Dis 69:1446\u20131455. https:\/\/doi.org\/10.1093\/cid\/ciz173","journal-title":"Clin Infect Dis"},{"key":"5352_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/jac\/dky028","volume":"73","author":"P Hemarajata","year":"2018","unstructured":"Hemarajata P, Amick T, Yang S, Gregson A, Holzmeyer C, Bush K, Humphries RM (2018) Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy. J Antimicrob Chemother 73:1256\u20131262. https:\/\/doi.org\/10.1093\/jac\/dky028","journal-title":"J Antimicrob Chemother"},{"key":"5352_CR6","doi-asserted-by":"publisher","first-page":"e00573","DOI":"10.1128\/AAC.00573-18","volume":"62","author":"A Gomez-Simmonds","year":"2018","unstructured":"Gomez-Simmonds A, Stump S, Giddins MJ, Annavajhala MK, Uhlemann AC (2018) Clonal background, resistance gene profile, and Porin gene mutations modulate in vitro susceptibility to imipenem-relebactam in diverse Enterobacteriaceae. Antimicrob Agents Chemother 62:e00573\u2013e00518. https:\/\/doi.org\/10.1128\/AAC.00573-18","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR7","doi-asserted-by":"publisher","first-page":"107081","DOI":"10.1016\/j.ijantimicag.2023.107081","volume":"63","author":"S Mushtaq","year":"2024","unstructured":"Mushtaq S, Vickers A, Woodford N, Livermore DM (2024) Activity of aztreonam\/avibactam and ceftazidime\/avibactam against enterobacterales with carbapenemase-independent carbapenem resistance. Int J Antimicrob Agents 63:107081. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107081","journal-title":"Int J Antimicrob Agents"},{"key":"5352_CR8","doi-asserted-by":"publisher","first-page":"106439","DOI":"10.1016\/j.ijantimicag.2021.106439","volume":"58","author":"M Castanheira","year":"2021","unstructured":"Castanheira M, Doyle TB, Deshpande LM, Mendes RE, Sader HS (2021) Activity of ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam against carbapenemase-negative carbapenem-resistant enterobacterales isolates from US hospitals. Int J Antimicrob Agents 58:106439. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106439","journal-title":"Int J Antimicrob Agents"},{"key":"5352_CR9","doi-asserted-by":"publisher","first-page":"e0077524","DOI":"10.1128\/aac.00775-24","volume":"68","author":"C Le Terrier","year":"2024","unstructured":"Le Terrier C, Mlynarcik P, Sadek M, Nordmann P, Poirel L (2024) Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone \u03b2-lactamase inhibitors against broad-spectrum AmpC \u03b2-lactamases. Antimicrob Agents Chemother 68:e0077524. https:\/\/doi.org\/10.1128\/aac.00775-24","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR10","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis 403. https:\/\/doi.org\/10.1093\/cid\/ciae403","DOI":"10.1093\/cid\/ciae403"},{"key":"5352_CR11","doi-asserted-by":"publisher","first-page":"e0130724","DOI":"10.1128\/aac.01307-24","volume":"68","author":"S Rodr\u00edguez-Pallares","year":"2024","unstructured":"Rodr\u00edguez-Pallares S, Blanco-Mart\u00edn T, Lence E, Aja-Macaya P, S\u00e1nchez-Pe\u00f1a L, Gonz\u00e1lez-Pinto L, Rodr\u00edguez-Mayo M, Fern\u00e1ndez-Gonz\u00e1lez A, Gal\u00e1n-S\u00e1nchez F, Beceiro A, Gonz\u00e1lez-Bello C, Bou G, Arca-Su\u00e1rez J (2024) In vivo emergence of resistance to ceftazidime\/avibactam through modification of chromosomal AmpC \u03b2-lactamase in Klebsiella aerogenes. Antimicrob Agents Chemother 68:e0130724. https:\/\/doi.org\/10.1128\/aac.01307-24","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10096-024-05034-z","volume":"44","author":"S Rodr\u00edguez-Pallares","year":"2025","unstructured":"Rodr\u00edguez-Pallares S, Mateo-Vargas MA, Rodr\u00edguez-Iglesias MA, Arca-Su\u00e1rez J, Gal\u00e1n-S\u00e1nchez F (2025) Evolution of ceftazidime\/avibactam resistance and plasmid dynamics in OXA-48-producing Klebsiella spp. during long-term patient colonization. Eur J Clin Microbiol Infect Dis 44:807\u2013817. https:\/\/doi.org\/10.1007\/s10096-024-05034-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5352_CR13","doi-asserted-by":"publisher","first-page":"537e1","DOI":"10.1016\/j.cmi.2022.11.011","volume":"29","author":"V Di Pilato","year":"2023","unstructured":"Di Pilato V, Principe L, Andriani L, Aiezza N, Coppi M, Ricci S, Giani T, Luzzaro F, Rossolini GM (2023) Deciphering variable resistance to novel carbapenem-based \u03b2-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime\/avibactam. Clin Microbiol Infect 29:537e1-537e8. https:\/\/doi.org\/10.1016\/j.cmi.2022.11.011","journal-title":"Clin Microbiol Infect"},{"key":"5352_CR14","unstructured":"CLSI (2024) Performance standards for antimicrobial susceptibility testing. M100, Thirty-fourth Edition"},{"key":"5352_CR15","doi-asserted-by":"publisher","first-page":"000685","DOI":"10.1099\/mgen.0.000685","volume":"7","author":"O Schwengers","year":"2021","unstructured":"Schwengers O, Jelonek L, Dieckmann MA, Beyvers S, Blom J, Goesmann A (2021) Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification. Microb Genom 7:000685. https:\/\/doi.org\/10.1099\/mgen.0.000685","journal-title":"Microb Genom"},{"key":"5352_CR16","doi-asserted-by":"publisher","first-page":"D690","DOI":"10.1093\/nar\/gkac920","volume":"51","author":"BP Alcock","year":"2023","unstructured":"Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, Edalatmand A, Petkau A, Syed SA, Tsang KK, Baker SJC, Dave M, McCarthy MC, Mukiri KM, Nasir JA, Golbon B, Imtiaz H, Jiang X, Kaur K, Kwong M, Liang ZC, Niu KC, Shan P, Yang JYJ, Gray KL, Hoad GR, Jia B, Bhando T, Carfrae LA, Farha MA, French S, Gordzevich R, Rachwalski K, Tu MM, Bordeleau E, Dooley D, Griffiths E, Zubyk HL, Brown ED, Maguire F, Beiko RG, Hsiao WWL, Brinkman FSL, Van Domselaar G, McArthur AG (2023) CARD 2023: expanded curation, support for machine learning, and resistome prediction at the comprehensive antibiotic resistance database. Nucleic Acids Res 51:D690\u2013D699. https:\/\/doi.org\/10.1093\/nar\/gkac920","journal-title":"Nucleic Acids Res"},{"key":"5352_CR17","unstructured":"Seemann T Snippy: fast bacterial variant calling from NGS reads [Internet]. Available at: https:\/\/github.com\/tseemann\/snippy"},{"key":"5352_CR18","unstructured":"Hackl T, Ankenbrand M, van Adrichem B, Wilkins D, Haslinger K (2024) Gggenomes: effective and versatile visualizations for comparative genomics. https:\/\/arxiv.org\/abs\/2411.13556v1"},{"key":"5352_CR19","doi-asserted-by":"publisher","first-page":"107150","DOI":"10.1016\/j.ijantimicag.2024.107150","volume":"63","author":"T Blanco-Mart\u00edn","year":"2024","unstructured":"Blanco-Mart\u00edn T, Alonso-Garc\u00eda I, Gonz\u00e1lez-Pinto L, Outeda-Garc\u00eda M, Guijarro-S\u00e1nchez P, L\u00f3pez-Hern\u00e1ndez I, P\u00e9rez-V\u00e1zquez M, Aracil B, L\u00f3pez-Cerero L, Fraile-Ribot P, Oliver A, V\u00e1zquez-Ucha JC, Beceiro A, Bou G, Arca-Su\u00e1rez J (2024) Activity of cefiderocol and innovative \u03b2-lactam\/\u03b2-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double \u03b2-lactamases under high and low permeability conditions. Int J Antimicrob Agents 63:107150. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107150. GEMARA\/SEIMC-CIBERINFEC Study Group on the activity and resistance mechanisms to new \u03b2-lactams and \u03b2-lactamase inhibitors (PROTECT)","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"5352_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1128\/AAC.43.4.902","volume":"43","author":"N Laraki","year":"1999","unstructured":"Laraki N, Franceschini N, Rossolini GM, Santucci P, Meunier C, De Pauw E, Amicosante G, Fr\u00e8re JM, Galleni M (1999) Biochemical characterization of the Pseudomonas aeruginosa 101\/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli. Antimicrob Agents Chemother 43(4):902\u2013906. https:\/\/doi.org\/10.1128\/AAC.43.4.902","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5352_CR21","doi-asserted-by":"publisher","first-page":"e01851","DOI":"10.1128\/AAC.01851-17","volume":"62","author":"A Piccirilli","year":"2018","unstructured":"Piccirilli A, Mercuri PS, Galleni M, Aschi M, Matagne A, Amicosante G, Perilli M (2018) P174E substitution in GES-1 and GES-5 \u03b2-Lactamases improves catalytic efficiency toward carbapenems. Antimicrob Agents Chemother 62(5):e01851\u2013e01817. https:\/\/doi.org\/10.1128\/AAC.01851-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5352_CR22","doi-asserted-by":"publisher","first-page":"e0029225","DOI":"10.1128\/aac.00292-25","volume":"69","author":"L Gonz\u00e1lez-Pinto","year":"2025","unstructured":"Gonz\u00e1lez-Pinto L, Gomis-Font MA, Lence E, Outeda-Garc\u00eda M, Blanco-Mart\u00edn T, Rodr\u00edguez-Pallares S, S\u00e1nchez-Pe\u00f1a L, Alonso-Garc\u00eda I, V\u00e1zquez-Ucha JC, Beceiro A, Bou G, Gonz\u00e1lez-Bello C, Oliver A, Arca-Su\u00e1rez J (2025) Functional and structural analyses of amino acid sequence variation in PDC \u03b2-lactamase reveal different mechanistic pathways toward Cefiderocol resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 69(7):e0029225. https:\/\/doi.org\/10.1128\/aac.00292-25","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jgar.2024.11.013","volume":"40","author":"W Chen","year":"2024","unstructured":"Chen W, Li Z, Zheng J, Wang D, Gao S, Zhou W, Shen H, Zhang Y, Cao X (2024) A comprehensive analysis of the epidemiological and genomic characteristics of global Serratia marcescens. J Glob Antimicrob Resist 40:81\u201389. https:\/\/doi.org\/10.1016\/j.jgar.2024.11.013","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"5352_CR24","doi-asserted-by":"publisher","first-page":"126055","DOI":"10.1016\/j.syapm.2020.126055","volume":"43","author":"GS Cho","year":"2020","unstructured":"Cho GS, Stein M, Brinks E, Rathje J, Lee W, Suh SH, Franz CMAP (2020) Serratia nevei sp. nov. and Serratia bockelmannii sp. nov., isolated from fresh produce in Germany and re-classification of Serratia marcescens subsp. sakuensis Ajithkumar et al. 2003 as a later heterotypic synonym of Serratia marcescens subsp. marcescens. Syst Appl Microbiol 43(2):126055. https:\/\/doi.org\/10.1016\/j.syapm.2020.126055","journal-title":"Syst Appl Microbiol"},{"issue":"4","key":"5352_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/jac\/dkg133","volume":"51","author":"SD Mahlen","year":"2003","unstructured":"Mahlen SD, Morrow SS, Abdalhamid B, Hanson ND (2003) Analyses of AmpC gene expression in Serratia marcescens reveal new regulatory properties. J Antimicrob Chemother 51(4):791\u2013802. https:\/\/doi.org\/10.1093\/jac\/dkg133","journal-title":"J Antimicrob Chemother"},{"key":"5352_CR26","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1099\/00221287-143-8-2797","volume":"143","author":"JA Hutsul","year":"1997","unstructured":"Hutsul JA, Worobec E (1997) Molecular characterization of the Serratia marcescens OmpF porin, and analysis of S. marcescens OmpF and OmpC osmoregulation. Microbiology 143:2797\u20132806. https:\/\/doi.org\/10.1099\/00221287-143-8-2797","journal-title":"Microbiology"},{"key":"5352_CR27","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1099\/mic.0.081166-0","volume":"160","author":"A Moya-Torres","year":"2014","unstructured":"Moya-Torres A, Mulvey MR, Kumar A, Oresnik IJ, Brassinga AKC (2014) The lack of OmpF, but not OmpC, contributes to increased antibiotic resistance in Serratia marcescens. Microbiology 160:1882\u20131892. https:\/\/doi.org\/10.1099\/mic.0.081166-0","journal-title":"Microbiology"},{"key":"5352_CR28","doi-asserted-by":"publisher","first-page":"e0112024","DOI":"10.1128\/aac.01120-24","volume":"68","author":"T Blanco-Mart\u00edn","year":"2024","unstructured":"Blanco-Mart\u00edn T, Gonz\u00e1lez-Pinto L, Aja-Macaya P, Rodr\u00edguez-Pallares S, S\u00e1nchez-Pe\u00f1a L, Gato E, Fern\u00e1ndez-L\u00f3pez MdC, Outeda-Garc\u00eda M, Rodr\u00edguez-Coello A, Pedraza-Merino R, Alonso-Garc\u00eda I, V\u00e1zquez-Ucha JC, Mart\u00ednez-Mart\u00ednez L, Arca-Su\u00e1rez J, Beceiro A, Bou G (2024) Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to Imipenem and Imipenem\/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime\/avibactam resistance. Antimicrob Agents Chemother 68:e0112024. https:\/\/doi.org\/10.1128\/aac.01120-24","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR29","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1128\/AAC.38.9.2150","volume":"38","author":"M Gonzalez Leiza","year":"1994","unstructured":"Gonzalez Leiza M, Perez-Diaz JC, Ayala J, Casellas JM, Martinez-Beltran J, Bush K, Baquero F (1994) Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother 38:2150\u20132157. https:\/\/doi.org\/10.1128\/AAC.38.9.2150","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR30","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1128\/AAC.44.9.2549-2553.2000","volume":"44","author":"G Bou","year":"2000","unstructured":"Bou G, Oliver A, Ojeda M, Monzon C, Martinez-Beltran J (2000) Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob Agents Chemother 44:2549\u20132553. https:\/\/doi.org\/10.1128\/AAC.44.9.2549-2553.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR31","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1128\/AAC.45.11.3189-3194.2001","volume":"45","author":"AM Queenan","year":"2001","unstructured":"Queenan AM, Jenkins S, Bush K (2001) Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded \u03b2-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother 45:3189\u201394. https:\/\/doi.org\/10.1128\/AAC.45.11.3189-3194.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR32","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1128\/AAC.00818-13","volume":"57","author":"FJ P\u00e9rez-Llarena","year":"2013","unstructured":"P\u00e9rez-Llarena FJ, Kerff F, Zamorano L, Fern\u00e1ndez MC, Nu\u00f1ez ML, Mir\u00f3 E, Oliver A, Navarro F, Bou G (2013) Characterization of the new AmpC \u03b2-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 loop that affects ceftazidime hydrolysis. Antimicrob Agents Chemother 57:5158\u20135161. https:\/\/doi.org\/10.1128\/AAC.00818-13","journal-title":"Antimicrob Agents Chemother"},{"key":"5352_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ijantimicag.2006.01.005","volume":"27","author":"F Fern\u00e1ndez-Cuenca","year":"2006","unstructured":"Fern\u00e1ndez-Cuenca F, Rodr\u00edguez-Mart\u00ednez JM, Mart\u00ednez-Mart\u00ednez L, Pascual A (2006) In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40\u00a0kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. Int J Antimicrob Agents 27:549\u2013552. https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.01.005","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"5352_CR34","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1128\/AAC.00818-13","volume":"7","author":"FJ P\u00e9rez-Llarena","year":"2013","unstructured":"P\u00e9rez-Llarena FJ, Kerff F, Zamorano L, Fern\u00e1ndez MC, Nu\u00f1ez ML, Mir\u00f3 E, Oliver A, Navarro F, Bou G (2013) Characterization of the new AmpC \u03b2-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 loop that affects ceftazidime hydrolysis. Antimicrob Agents Chemother 7(10):5158\u20135161. https:\/\/doi.org\/10.1128\/AAC.00818-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5352_CR35","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/jac\/dkq115","volume":"65","author":"S Mallo","year":"2010","unstructured":"Mallo S, P\u00e9rez-Llarena FJ, Kerff F, Soares NC, Galleni M, Bou G (2010) A tripeptide deletion in the R2 loop of the class C -lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to -lactamase inhibitors. J Antimicrob Chemother 65(6):1187\u20131194. https:\/\/doi.org\/10.1093\/jac\/dkq115","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5352_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/CMR.00037-09","volume":"23","author":"SM Drawz","year":"2010","unstructured":"Drawz SM, Bonomo RA (2010) Three decades of \u03b2-lactamase inhibitors. Clin Microbiol Rev 23(1):160\u2013201. https:\/\/doi.org\/10.1128\/CMR.00037-09","journal-title":"Clin Microbiol Rev"},{"issue":"18","key":"5352_CR37","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL TTooke","year":"2019","unstructured":"TTooke CL, Hinchliffe P, Bragginton EC, Colenso CK, Hirvonen VHA, Takebayashi Y, Spencer J (2019) \u03b2-Lactamases and \u03b2-Lactamase inhibitors in the 21st century. J Mol Biol 431(18):3472\u20133500. https:\/\/doi.org\/10.1016\/j.jmb.2019.04.002","journal-title":"J Mol Biol"},{"issue":"6","key":"5352_CR38","doi-asserted-by":"publisher","first-page":"e02311","DOI":"10.1128\/AAC.02311-19","volume":"64","author":"F Compain","year":"2020","unstructured":"Compain F, Debray A, Adjadj P, Dorch\u00eane D, Arthur M (2020) Ceftazidime-avibactam resistance mediated by the N346Y substitution in various AmpC \u03b2-lactamases. Antimicrob Agents Chemother 64(6):e02311\u2013e02319. https:\/\/doi.org\/10.1128\/AAC.02311-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5352_CR39","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ijantimicag.2019.09.017","volume":"54","author":"S Ebmeyer","year":"2019","unstructured":"Ebmeyer S, Kristiansson E, Larsson DGJ (2019) The mobile FOX AmpC beta-lactamases originated in Aeromonas allosaccharophila. Int J Antimicrob Agents 54(6):798\u2013802. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.09.017","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"5352_CR40","doi-asserted-by":"publisher","first-page":"e0044125","DOI":"10.1128\/aac.00441-25","volume":"69","author":"L Nong","year":"2025","unstructured":"Nong L, Liu X, Wang X, de Leeuw W, Jonker M, Brul S, Ter Kuile B (2025) Driving factors for beta-lactam resistance gene amplification during de Novo resistance evolution in E. coli. Antimicrob Agents Chemother 69(9):e0044125. https:\/\/doi.org\/10.1128\/aac.00441-25","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5352_CR41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrmicro2174","volume":"7","author":"L Sandegren","year":"2009","unstructured":"Sandegren L, Andersson DI (2009) Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nat Rev Microbiol 7(8):578\u2013588. https:\/\/doi.org\/10.1038\/nrmicro2174","journal-title":"Nat Rev Microbiol"},{"key":"5352_CR42","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/jac\/dkae265","volume":"79","author":"A Davin-Regli","year":"2024","unstructured":"Davin-Regli A, Pag\u00e8s J-M, Vergalli J (2024) The contribution of porins to enterobacterial drug resistance. J Antimicrob Chemother 79:2460\u20132470. https:\/\/doi.org\/10.1093\/jac\/dkae265","journal-title":"J Antimicrob Chemother"},{"key":"5352_CR43","doi-asserted-by":"publisher","first-page":"106011","DOI":"10.1016\/j.ijantimicag.2020.106011","volume":"56","author":"M Castanheira","year":"2020","unstructured":"Castanheira M, Doyle TB, Hubler C, Sader HS, Mendes RE (2020) Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant enterobacterales: Ompk36 L3 alterations and \u03b2-lactamases with Ceftazidime hydrolytic activity lead to elevated MIC values. Int J Antimicrob Agents 56:106011. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106011","journal-title":"Int J Antimicrob Agents"},{"key":"5352_CR44","doi-asserted-by":"publisher","first-page":"107425","DOI":"10.1016\/j.ijantimicag.2024.107425","volume":"65","author":"X Xiang","year":"2025","unstructured":"Xiang X, Kong J, Zhang J, Zhang X, Qian C, Zhou T, Sun Y (2025) Multiple mechanisms mediate aztreonam-avibactam resistance in Klebsiella pneumoniae: driven by KPC-2 and OmpK36 mutations. Int J Antimicrob Agents 65:107425. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107425","journal-title":"Int J Antimicrob Agents"},{"key":"5352_CR45","doi-asserted-by":"publisher","first-page":"106935","DOI":"10.1016\/j.ijantimicag.2023.106935","volume":"62","author":"E Gato","year":"2023","unstructured":"Gato E, Guijarro-S\u00e1nchez P, Alonso-Garc\u00eda I, Pedraza-Merino R, Conde A, Lence E, Rumbo-Feal S, Pe\u00f1a-Escolano A, Lasarte-Monterrubio C, Blanco-Mart\u00edn T, Fern\u00e1ndez-Gonz\u00e1lez A, Fern\u00e1ndez-L\u00f3pez MDC, Maceiras R, Mart\u00ednez-Guiti\u00e1n M, V\u00e1zquez-Ucha JC, Mart\u00ednez-Mart\u00ednez L, Gonz\u00e1lez-Bello C, Arca-Su\u00e1rez J, Beceiro A, Bou G (2023) In vitro development of imipenem\/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification. Int J Antimicrob Agents 62:106935. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106935","journal-title":"Int J Antimicrob Agents"},{"key":"5352_CR46","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s10096-024-04958-w","volume":"43","author":"M Boattini","year":"2024","unstructured":"Boattini M, Bianco G, Comini S, Costa C, Gaibani P (2024) In vivo development of resistance to novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series. Eur J Clin Microbiol Infect Dis 43:2407\u20132417. https:\/\/doi.org\/10.1007\/s10096-024-04958-w","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05352-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05352-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05352-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:39:54Z","timestamp":1773495594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05352-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5352"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05352-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.B. has received funding and study materials from MSD, grants contracts from MSD, Pfizer, ABAC Therapeutics and Roche, consulting fees and honoraria for lectures and\/or presentations from MSD, Shionogi Pfizer, Roche and Menarini, and support for attending meetings and\/or travels from Pfizer. J.A.-S. has received honoraria for lectures, consulting fees and\/or presentations from MSD, Shionogi, Pfizer, and Advanz Pharma. All other authors: none to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}